EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus

According to international consensus, metformin is acknowledged as a first-line therapeutic agent for type 2 diabetes mellitus (T2DM). However, in most cases this treatment eventually requires intensification by supplementation with other hypoglycemic medications. The aim of the EDGE study (Effectiv...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Gagik Radikovich Galstyan
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2013
Materias:
Acceso en línea:https://doaj.org/article/05a818a1512f45d2a2c1afbc3ea75738
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!